InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.30
(
0.65%
)
Bitcoin
63,735.45
(
-0.25%
)
Post# of 251720
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nohogs

Send PM Follow Ignore
Followers 2
Posts 704
Boards Moderated 0
Alias Born 03/29/2006

nohogs

Re: None

Monday, 08/08/2016 2:03:40 PM

Monday, August 08, 2016 2:03:40 PM

Post# of 251720
I know it is a microcap but I see Keytruda mentioned here and $PBMD has an ongoing trial of their lag3 drug being combined with Keytruda. BMS is also conducting a similar trial with Opdivo and their lag3 drug that is under development. Prima's CSO discovered lag3 in 1990 and pre-clinical studies of anti-lag3 agents and anti-pd-1 inhibitor therapies have yielded encouraging results. All DD on PBMD has been updated in the ibox on that board. Thanks.

http://investorshub.advfn.com/Prima-Biomed-Ltd-PBMD-20680/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up